MCA logo

PUBLIC PORTAL

invest selangor

MEDICALLY REVIEWED

Galderma Secures Approval for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Countries

Atopic Dermatitis NEMOLIZUMAB galderma
Galderma, a global dermatology company, has received filing acceptances for its breakthrough treatment nemolizumab. The drug is designed to treat prurigo nodularis and moderate-to-severe atopic dermatitis in adolescents and adults. It received regulatory nods from authorities in Australia, Singapore, Switzerland, and the United Kingdom via the Access Consortium framework.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

polio malaysia vaccination
Polio: An In-Depth Look at the Debilitating Disease and Efforts to Eradicate It

Polio, also known as poliomyelitis, is a highly infectious viral disease that primarily affects young children. Once a widespread and feared illness, polio has been largely eliminated in most parts of the world, thanks to extensive vaccination efforts. This article will explore the history, causes, symptoms, and treatments for polio, as well as the ongoing global efforts to eradicate the disease.

Read More »